A citation-based method for searching scientific literature

Nayoung Kim, Ningning He, Changsik Kim, Fan Zhang, Yiling Lu, Qinghua Yu, Katherine Stemke-Hale, Joel Greshock, Richard Wooster, Sukjoon Yoon, Gordon B Mills. Int J Cancer 2012
Times Cited: 25







List of co-cited articles
59 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
32

Molecular target class is predictive of in vitro response profile.
Joel Greshock, Kurtis E Bachman, Yan Y Degenhardt, Junping Jing, Yuan H Wen, Stephen Eastman, Elizabeth McNeil, Christopher Moy, Ronald Wegrzyn, Kurt Auger,[...]. Cancer Res 2010
89
24

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
Ultan McDermott, Sreenath V Sharma, Lori Dowell, Patricia Greninger, Clara Montagut, Jennifer Lamb, Heidi Archibald, Raul Raudales, Angela Tam, Diana Lee,[...]. Proc Natl Acad Sci U S A 2007
262
24

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.
Simon A Forbes, Nidhi Bindal, Sally Bamford, Charlotte Cole, Chai Yin Kok, David Beare, Mingming Jia, Rebecca Shepherd, Kenric Leung, Andrew Menzies,[...]. Nucleic Acids Res 2011
20

Systematic identification of genomic markers of drug sensitivity in cancer cells.
Mathew J Garnett, Elena J Edelman, Sonja J Heidorn, Chris D Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I Richard Thompson, Xi Luo, Jorge Soares,[...]. Nature 2012
20

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
D A Scudiero, R H Shoemaker, K D Paull, A Monks, S Tierney, T H Nofziger, M J Currens, D Seniff, M R Boyd. Cancer Res 1988
16

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Richard M Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L Baehner, Tea Fevr, Laura Clark, Nora Bayani, Jean-Philippe Coppe, Frances Tong,[...]. Cancer Cell 2006
16

QCanvas: An Advanced Tool for Data Clustering and Visualization of Genomics Data.
Nayoung Kim, Herin Park, Ningning He, Hyeon Young Lee, Sukjoon Yoon. Genomics Inform 2012
22
18

Cluster analysis and display of genome-wide expression patterns.
M B Eisen, P T Spellman, P O Brown, D Botstein. Proc Natl Acad Sci U S A 1998
12

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
Satoshi Nishizuka, Lu Charboneau, Lynn Young, Sylvia Major, William C Reinhold, Mark Waltham, Hosein Kouros-Mehr, Kimberly J Bussey, Jae K Lee, Virginia Espina,[...]. Proc Natl Acad Sci U S A 2003
329
12

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
Filip Janku, Jennifer J Wheler, Shannon N Westin, Stacy L Moulder, Aung Naing, Apostolia M Tsimberidou, Siqing Fu, Gerald S Falchook, David S Hong, Ignacio Garrido-Laguna,[...]. J Clin Oncol 2012
323
12


3D shape-based analysis of cell line-specific compound response in cancers.
Ningning He, Xiaoqi Wang, Nayoung Kim, Jong-Seok Lim, Sukjoon Yoon. J Mol Graph Model 2013
3
100

CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.
William C Reinhold, Margot Sunshine, Hongfang Liu, Sudhir Varma, Kurt W Kohn, Joel Morris, James Doroshow, Yves Pommier. Cancer Res 2012
252
12

Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.
Ningning He, Nayoung Kim, Mee Song, Choa Park, Somin Kim, Eun Young Park, Hwa Young Yim, Kyunga Kim, Jong Hoon Park, Keun Il Kim,[...]. Mol Cancer Ther 2014
8
37

MACE: mutation-oriented profiling of chemical response and gene expression in cancers.
Euna Jeong, Ningning He, Hyerin Park, Mee Song, Nayoung Kim, Seongjoon Lee, Sukjoon Yoon. Bioinformatics 2015
4
75

The NCI60 human tumour cell line anticancer drug screen.
Robert H Shoemaker. Nat Rev Cancer 2006
12

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
Wanjuan Yang, Jorge Soares, Patricia Greninger, Elena J Edelman, Howard Lightfoot, Simon Forbes, Nidhi Bindal, Dave Beare, James A Smith, I Richard Thompson,[...]. Nucleic Acids Res 2013
718
12

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
8


MicroRNA expression profiles for the NCI-60 cancer cell panel.
Paul E Blower, Joseph S Verducci, Shili Lin, Jin Zhou, Ji-Hyun Chung, Zunyan Dai, Chang-Gong Liu, William Reinhold, Philip L Lorenzi, Eric P Kaldjian,[...]. Mol Cancer Ther 2007
170
8

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
532
8

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Ogechi N Ikediobi, Helen Davies, Graham Bignell, Sarah Edkins, Claire Stevens, Sarah O'Meara, Thomas Santarius, Tim Avis, Syd Barthorpe, Lisa Brackenbury,[...]. Mol Cancer Ther 2006
283
8

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
J S Lee, K Paull, M Alvarez, C Hose, A Monks, M Grever, A T Fojo, S E Bates. Mol Pharmacol 1994
246
8

Cytosine methylation profiling of cancer cell lines.
Mathias Ehrich, Julia Turner, Peter Gibbs, Lara Lipton, Mara Giovanneti, Charles Cantor, Dirk van den Boom. Proc Natl Acad Sci U S A 2008
94
8

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.
Uma T Shankavaram, William C Reinhold, Satoshi Nishizuka, Sylvia Major, Daisaku Morita, Krishna K Chary, Mark A Reimers, Uwe Scherf, Ari Kahn, Douglas Dolginow,[...]. Mol Cancer Ther 2007
215
8

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Levi A Garraway, Hans R Widlund, Mark A Rubin, Gad Getz, Aaron J Berger, Sridhar Ramaswamy, Rameen Beroukhim, Danny A Milner, Scott R Granter, Jinyan Du,[...]. Nature 2005
958
8

The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
8



Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
8

Subtype and pathway specific responses to anticancer compounds in breast cancer.
Laura M Heiser, Anguraj Sadanandam, Wen-Lin Kuo, Stephen C Benz, Theodore C Goldstein, Sam Ng, William J Gibb, Nicholas J Wang, Safiyyah Ziyad, Frances Tong,[...]. Proc Natl Acad Sci U S A 2012
288
8

Modeling precision treatment of breast cancer.
Anneleen Daemen, Obi L Griffith, Laura M Heiser, Nicholas J Wang, Oana M Enache, Zachary Sanborn, Francois Pepin, Steffen Durinck, James E Korkola, Malachi Griffith,[...]. Genome Biol 2013
151
8

Systematic variation in gene expression patterns in human cancer cell lines.
D T Ross, U Scherf, M B Eisen, C M Perou, C Rees, P Spellman, V Iyer, S S Jeffrey, M Van de Rijn, M Waltham,[...]. Nat Genet 2000
8

Development of human tumor cell line panels for use in disease-oriented drug screening.
R H Shoemaker, A Monks, M C Alley, D A Scudiero, D L Fine, T L McLemore, B J Abbott, K D Paull, J G Mayo, M R Boyd. Prog Clin Biol Res 1988
54
8

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.
K D Paull, R H Shoemaker, L Hodes, A Monks, D A Scudiero, L Rubinstein, J Plowman, M R Boyd. J Natl Cancer Inst 1989
567
8

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.
Eun Sung Park, Rosalia Rabinovsky, Mark Carey, Bryan T Hennessy, Roshan Agarwal, Wenbin Liu, Zhenlin Ju, Wanleng Deng, Yiling Lu, Hyun Goo Woo,[...]. Mol Cancer Ther 2010
66
8

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.
Kimberly J Bussey, Koei Chin, Samir Lababidi, Mark Reimers, William C Reinhold, Wen-Lin Kuo, Fuad Gwadry, Ajay, Hosein Kouros-Mehr, Jane Fridlyand,[...]. Mol Cancer Ther 2006
115
8

Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
John F Deeken, Robert W Robey, Suneet Shukla, Kenneth Steadman, Arup R Chakraborty, Balasubramanian Poonkuzhali, Erin G Schuetz, Susan Holbeck, Suresh V Ambudkar, Susan E Bates. Mol Pharmacol 2009
18
11

Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling.
Y Lu, M Muller, D Smith, B Dutta, K Komurov, S Iadevaia, D Ruths, J T Tseng, S Yu, Q Yu,[...]. Oncogene 2011
49
8


Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.
Anirudh Prahallad, Chong Sun, Sidong Huang, Federica Di Nicolantonio, Ramon Salazar, Davide Zecchin, Roderick L Beijersbergen, Alberto Bardelli, René Bernards. Nature 2012
8


The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Ogan D Abaan, Eric C Polley, Sean R Davis, Yuelin J Zhu, Sven Bilke, Robert L Walker, Marbin Pineda, Yevgeniy Gindin, Yuan Jiang, William C Reinhold,[...]. Cancer Res 2013
178
8

p53 and human cancer: the first ten thousand mutations.
P Hainaut, M Hollstein. Adv Cancer Res 2000
574
8

Patterns of somatic mutation in human cancer genomes.
Christopher Greenman, Philip Stephens, Raffaella Smith, Gillian L Dalgliesh, Christopher Hunter, Graham Bignell, Helen Davies, Jon Teague, Adam Butler, Claire Stevens,[...]. Nature 2007
8

Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
8

Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.
Zhu A Wang, Antonina Mitrofanova, Sarah K Bergren, Cory Abate-Shen, Robert D Cardiff, Andrea Califano, Michael M Shen. Nat Cell Biol 2013
189
8

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Montserrat Sanchez-Cespedes, Paola Parrella, Manel Esteller, Shuji Nomoto, Barry Trink, James M Engles, William H Westra, James G Herman, David Sidransky. Cancer Res 2002
410
8

LKB1 modulates lung cancer differentiation and metastasis.
Hongbin Ji, Matthew R Ramsey, D Neil Hayes, Cheng Fan, Kate McNamara, Piotr Kozlowski, Chad Torrice, Michael C Wu, Takeshi Shimamura, Samanthi A Perera,[...]. Nature 2007
658
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.